chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error, Product temperature excursion issue
Clinical narrative: Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days.; The vaccine was administered to about 9 to 10 patients before the excursion error was discovered; vaccine expired by 1 day/Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days.), PRODUCT TEMPERATURE EXCURSION ISSUE (The vaccine was administered to about 9 to 10 patients before the excursion error was discovered) and EXPIRED PRODUCT ADMINISTERED (vaccine expired by 1 day/Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008c21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days.), PRODUCT TEMPERATURE EXCURSION ISSUE (The vaccine was administered to about 9 to 10 patients before the excursion error was discovered) and EXPIRED PRODUCT ADMINISTERED (vaccine expired by 1 day/Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days). At the time of the report, PRODUCT STORAGE ERROR (Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days.), PRODUCT TEMPERATURE EXCURSION ISSUE (The vaccine was administered to about 9 to 10 patients before the excursion error was discovered) and EXPIRED PRODUCT ADMINISTERED (vaccine expired by 1 day/Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were provided by the reporter.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error, Product temperature excursion issue
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days), PRODUCT TEMPERATURE EXCURSION ISSUE (The vaccine was administered to about 9 to 10 patients before the excursion error was discovered) and EXPIRED PRODUCT ADMINISTERED (vaccine expired by 1 day) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008C21A and 008C21A) for COVID-19 vaccination. No Medical History information was reported. On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced PRODUCT STORAGE ERROR (Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days), PRODUCT TEMPERATURE EXCURSION ISSUE (The vaccine was administered to about 9 to 10 patients before the excursion error was discovered) and EXPIRED PRODUCT ADMINISTERED (vaccine expired by 1 day). At the time of the report, PRODUCT STORAGE ERROR (Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days) had not resolved and PRODUCT TEMPERATURE EXCURSION ISSUE (The vaccine was administered to about 9 to 10 patients before the excursion error was discovered) and EXPIRED PRODUCT ADMINISTERED (vaccine expired by 1 day) had resolved. No concomitant medications were reported. No treatment medications were provided by the reporter.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error, Product temperature excursion issue
Clinical narrative: Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days.; The vaccine was administered to about 9 to 10 patients before the excursion error was discovered; Vaccine expired by 1 day; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days.), PRODUCT TEMPERATURE EXCURSION ISSUE (The vaccine was administered to about 9 to 10 patients before the excursion error was discovered) and EXPIRED PRODUCT ADMINISTERED (Vaccine expired by 1 day) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008C21A and 008C21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Type of test : STPH).   On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days.), PRODUCT TEMPERATURE EXCURSION ISSUE (The vaccine was administered to about 9 to 10 patients before the excursion error was discovered) and EXPIRED PRODUCT ADMINISTERED (Vaccine expired by 1 day). At the time of the report, PRODUCT STORAGE ERROR (Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days.), PRODUCT TEMPERATURE EXCURSION ISSUE (The vaccine was administered to about 9 to 10 patients before the excursion error was discovered) and EXPIRED PRODUCT ADMINISTERED (Vaccine expired by 1 day) had resolved.            No relevant concomitant medications reported. No treatment information was provided.   This case was linked to MOD-2021-207778 (Patient Link).
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error, Product temperature excursion issue
Clinical narrative: Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days.; The vaccine was administered to about 9 to 10 patients before the excursion error was discovered; vaccine expired by 1 day; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days.), PRODUCT TEMPERATURE EXCURSION ISSUE (The vaccine was administered to about 9 to 10 patients before the excursion error was discovered) and EXPIRED PRODUCT ADMINISTERED (vaccine expired by 1 day) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008c21A and 008c21A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days.), PRODUCT TEMPERATURE EXCURSION ISSUE (The vaccine was administered to about 9 to 10 patients before the excursion error was discovered) and EXPIRED PRODUCT ADMINISTERED (vaccine expired by 1 day). At the time of the report, PRODUCT STORAGE ERROR (Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days.), PRODUCT TEMPERATURE EXCURSION ISSUE (The vaccine was administered to about 9 to 10 patients before the excursion error was discovered) and EXPIRED PRODUCT ADMINISTERED (vaccine expired by 1 day) had resolved.            No concomitant medications were reported. No treatment medications were provided by the reporter.   This case was linked to MOD-2021-207778 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error, Product temperature excursion issue
Clinical narrative: Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days.; The vaccine was administered to about 9 to 10 patients before the excursion error was discovered; vaccine expired by 1 day/Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days.), PRODUCT TEMPERATURE EXCURSION ISSUE (The vaccine was administered to about 9 to 10 patients before the excursion error was discovered) and EXPIRED PRODUCT ADMINISTERED (vaccine expired by 1 day/Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008c21A and 008C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days.), PRODUCT TEMPERATURE EXCURSION ISSUE (The vaccine was administered to about 9 to 10 patients before the excursion error was discovered) and EXPIRED PRODUCT ADMINISTERED (vaccine expired by 1 day/Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days). At the time of the report, PRODUCT STORAGE ERROR (Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days.), PRODUCT TEMPERATURE EXCURSION ISSUE (The vaccine was administered to about 9 to 10 patients before the excursion error was discovered) and EXPIRED PRODUCT ADMINISTERED (vaccine expired by 1 day/Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days) had resolved.            No Concomitant medications were provided by the reporter. No Treatment information was reported.   This case was linked to MOD-2021-207778 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Myalgia, Nasopharyngitis
Clinical narrative: Cold; Aches/pains; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Cold) and MYALGIA (Aches/pains) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (Cold) and MYALGIA (Aches/pains). At the time of the report, NASOPHARYNGITIS (Cold) and MYALGIA (Aches/pains) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment information was not provided by the reporter.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Hypoaesthesia, Pain, Paraesthesia
Clinical narrative: felt like a needle/Pins & needles toes; numbness in toes of his left foot; burning sensation, and numbness in toes of his left foot/burning sensation and transitioning back and forth between these; stinging, burning sensation, and numbness in toes of his left foot; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (felt like a needle/Pins & needles toes), HYPOAESTHESIA (numbness in toes of his left foot), BURNING SENSATION (burning sensation, and numbness in toes of his left foot/burning sensation and transitioning back and forth between these) and PAIN (stinging, burning sensation, and numbness in toes of his left foot) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension since 15-Jun-2015. Concomitant products included HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL HCT [HYDROCHLOROTHIAZIDE;LISINOPRIL]) from 15-Jun-2015 to an unknown date, CENTRUM SILVER +50 and COLECALCIFEROL, FISH OIL (FISH OIL + VITAMIN D3) for an unknown indication.    On 24-Jul-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Aug-2021, the patient experienced BURNING SENSATION (burning sensation, and numbness in toes of his left foot/burning sensation and transitioning back and forth between these) and PAIN (stinging, burning sensation, and numbness in toes of his left foot). On 03-Aug-2021 at 7:00 AM, the patient experienced PARAESTHESIA (felt like a needle/Pins & needles toes) and HYPOAESTHESIA (numbness in toes of his left foot). On 05-Aug-2021, PARAESTHESIA (felt like a needle/Pins & needles toes), HYPOAESTHESIA (numbness in toes of his left foot) and PAIN (stinging, burning sensation, and numbness in toes of his left foot) had resolved. At the time of the report, BURNING SENSATION (burning sensation, and numbness in toes of his left foot/burning sensation and transitioning back and forth between these) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. Patient did not diagnosed with Covid-19.   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Significant FU (ADR Form): medical history, concomitant medication, route and time of vaccine administration updated and events (Paraesthesia and Hypoaesthesia) outcome updated to recovered from recovering. Patient did not diagnosed with Covid-19.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Had the first shot a few months ago an did not get the second shot; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Had the first shot a few months ago an did not get the second shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Had the first shot a few months ago an did not get the second shot). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Had the first shot a few months ago an did not get the second shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.   Reporter did not allow further contact
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Mild fever; Muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Mild fever) and MYALGIA (Muscle aches) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. ERH732) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Mild fever) and MYALGIA (Muscle aches). At the time of the report, PYREXIA (Mild fever) and MYALGIA (Muscle aches) outcome was unknown.            The concomitant medications were not reported. The treatment information was not provided.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Aphonia, Cough, Vaccination site pain
Clinical narrative: Vaccination site pain; Loss of voice; Cough; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Vaccination site pain), APHONIA (Loss of voice) and COUGH (Cough) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939G76 or 939676) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jul-2021, the patient experienced VACCINATION SITE PAIN (Vaccination site pain). In July 2021, the patient experienced APHONIA (Loss of voice) and COUGH (Cough). In July 2021, VACCINATION SITE PAIN (Vaccination site pain) and APHONIA (Loss of voice) had resolved. At the time of the report, COUGH (Cough) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Rash, Urticaria
Clinical narrative: Serious Rashes that are getting worse; Welts; Does not sleep well; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Serious Rashes that are getting worse), URTICARIA (Welts) and INSOMNIA (Does not sleep well) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M02A and 029A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH (Serious Rashes that are getting worse), URTICARIA (Welts) and INSOMNIA (Does not sleep well).   At the time of the report, RASH (Serious Rashes that are getting worse), URTICARIA (Welts) and INSOMNIA (Does not sleep well) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Formication
Clinical narrative: For 2 weeks something was crawling on my arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FORMICATION (For 2 weeks something was crawling on my arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FORMICATION (For 2 weeks something was crawling on my arm). At the time of the report, FORMICATION (For 2 weeks something was crawling on my arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use was unknown Treatment  information was unknown
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dyspnoea, Fatigue, Headache
Clinical narrative: Had a sore arm; shortness of breath; projectile vomiting; woke up with uncontrollable chills; headache; fever of 101.5; feels nauseas; tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Had a sore arm), DYSPNOEA (shortness of breath), VOMITING PROJECTILE (projectile vomiting), CHILLS (woke up with uncontrollable chills) and HEADACHE (headache) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 17-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Had a sore arm), DYSPNOEA (shortness of breath), VOMITING PROJECTILE (projectile vomiting), CHILLS (woke up with uncontrollable chills), HEADACHE (headache), PYREXIA (fever of 101.5), NAUSEA (feels nauseas) and FATIGUE (tired). At the time of the report, PAIN IN EXTREMITY (Had a sore arm), DYSPNOEA (shortness of breath), VOMITING PROJECTILE (projectile vomiting), CHILLS (woke up with uncontrollable chills), HEADACHE (headache), PYREXIA (fever of 101.5), NAUSEA (feels nauseas) and FATIGUE (tired) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) High.         No relevant concomitant medications were reported.  No treatment information was provided.    This case was linked to MOD-2021-081505 (Patient Link).
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Pyrexia, Vomiting projectile
Clinical narrative: Had a sore arm; shortness of breath; projectile vomiting; woke up with uncontrollable chills; headache; fever of 101.5; feels nauseas; tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Had a sore arm), DYSPNOEA (shortness of breath), VOMITING PROJECTILE (projectile vomiting), CHILLS (woke up with uncontrollable chills) and HEADACHE (headache) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 17-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Had a sore arm), DYSPNOEA (shortness of breath), VOMITING PROJECTILE (projectile vomiting), CHILLS (woke up with uncontrollable chills), HEADACHE (headache), PYREXIA (fever of 101.5), NAUSEA (feels nauseas) and FATIGUE (tired). At the time of the report, PAIN IN EXTREMITY (Had a sore arm), DYSPNOEA (shortness of breath), VOMITING PROJECTILE (projectile vomiting), CHILLS (woke up with uncontrollable chills), HEADACHE (headache), PYREXIA (fever of 101.5), NAUSEA (feels nauseas) and FATIGUE (tired) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) High.         No relevant concomitant medications were reported.  No treatment information was provided.    This case was linked to MOD-2021-081505 (Patient Link).
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Headache, Illness, Mobility decreased
Clinical narrative: She is sick; Everything hurts; Difficulty breathing; Chest feels tight; Throat feels tight; Won't be able to get out of bed; Didn't sleep well; Muscle ache; Pain in the arm of the injection; Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of POOR QUALITY SLEEP (Didn't sleep well), PAIN (Everything hurts), DYSPNOEA (Difficulty breathing), CHEST DISCOMFORT (Chest feels tight) and THROAT TIGHTNESS (Throat feels tight) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma.    On 01-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Aug-2021, the patient experienced VACCINATION SITE PAIN (Pain in the arm of the injection), HEADACHE (Headache) and NAUSEA (Nausea). On 03-Aug-2021, the patient experienced POOR QUALITY SLEEP (Didn't sleep well) and MYALGIA (Muscle ache). On 04-Aug-2021, the patient experienced PAIN (Everything hurts), DYSPNOEA (Difficulty breathing), CHEST DISCOMFORT (Chest feels tight), THROAT TIGHTNESS (Throat feels tight) and MOBILITY DECREASED (Won't be able to get out of bed). On an unknown date, the patient experienced ILLNESS (She is sick). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, POOR QUALITY SLEEP (Didn't sleep well), PAIN (Everything hurts), DYSPNOEA (Difficulty breathing), CHEST DISCOMFORT (Chest feels tight), THROAT TIGHTNESS (Throat feels tight), MOBILITY DECREASED (Won't be able to get out of bed), ILLNESS (She is sick), VACCINATION SITE PAIN (Pain in the arm of the injection), HEADACHE (Headache), NAUSEA (Nausea) and MYALGIA (Muscle ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications included an allergy medication and a rescue inhaler for asthma.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pain, Poor quality sleep, Throat tightness
Clinical narrative: She is sick; Everything hurts; Difficulty breathing; Chest feels tight; Throat feels tight; Won't be able to get out of bed; Didn't sleep well; Muscle ache; Pain in the arm of the injection; Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of POOR QUALITY SLEEP (Didn't sleep well), PAIN (Everything hurts), DYSPNOEA (Difficulty breathing), CHEST DISCOMFORT (Chest feels tight) and THROAT TIGHTNESS (Throat feels tight) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma.    On 01-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Aug-2021, the patient experienced VACCINATION SITE PAIN (Pain in the arm of the injection), HEADACHE (Headache) and NAUSEA (Nausea). On 03-Aug-2021, the patient experienced POOR QUALITY SLEEP (Didn't sleep well) and MYALGIA (Muscle ache). On 04-Aug-2021, the patient experienced PAIN (Everything hurts), DYSPNOEA (Difficulty breathing), CHEST DISCOMFORT (Chest feels tight), THROAT TIGHTNESS (Throat feels tight) and MOBILITY DECREASED (Won't be able to get out of bed). On an unknown date, the patient experienced ILLNESS (She is sick). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, POOR QUALITY SLEEP (Didn't sleep well), PAIN (Everything hurts), DYSPNOEA (Difficulty breathing), CHEST DISCOMFORT (Chest feels tight), THROAT TIGHTNESS (Throat feels tight), MOBILITY DECREASED (Won't be able to get out of bed), ILLNESS (She is sick), VACCINATION SITE PAIN (Pain in the arm of the injection), HEADACHE (Headache), NAUSEA (Nausea) and MYALGIA (Muscle ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications included an allergy medication and a rescue inhaler for asthma.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: She is sick; Everything hurts; Difficulty breathing; Chest feels tight; Throat feels tight; Won't be able to get out of bed; Didn't sleep well; Muscle ache; Pain in the arm of the injection; Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of POOR QUALITY SLEEP (Didn't sleep well), PAIN (Everything hurts), DYSPNOEA (Difficulty breathing), CHEST DISCOMFORT (Chest feels tight) and THROAT TIGHTNESS (Throat feels tight) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma.    On 01-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Aug-2021, the patient experienced VACCINATION SITE PAIN (Pain in the arm of the injection), HEADACHE (Headache) and NAUSEA (Nausea). On 03-Aug-2021, the patient experienced POOR QUALITY SLEEP (Didn't sleep well) and MYALGIA (Muscle ache). On 04-Aug-2021, the patient experienced PAIN (Everything hurts), DYSPNOEA (Difficulty breathing), CHEST DISCOMFORT (Chest feels tight), THROAT TIGHTNESS (Throat feels tight) and MOBILITY DECREASED (Won't be able to get out of bed). On an unknown date, the patient experienced ILLNESS (She is sick). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, POOR QUALITY SLEEP (Didn't sleep well), PAIN (Everything hurts), DYSPNOEA (Difficulty breathing), CHEST DISCOMFORT (Chest feels tight), THROAT TIGHTNESS (Throat feels tight), MOBILITY DECREASED (Won't be able to get out of bed), ILLNESS (She is sick), VACCINATION SITE PAIN (Pain in the arm of the injection), HEADACHE (Headache), NAUSEA (Nausea) and MYALGIA (Muscle ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications included an allergy medication and a rescue inhaler for asthma.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was given the vaccine beyond it's use date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was given the vaccine beyond it's use date) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Aug-2021 at 8:45 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Aug-2021 at 8:45 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was given the vaccine beyond it's use date). On 04-Aug-2021 at 8:45 AM, EXPIRED PRODUCT ADMINISTERED (Patient was given the vaccine beyond it's use date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The Moderna vial was punctured on 03-Aug-2021 at 8:50 am. Per storage and handling, the vaccine expired 03-Aug-2021 at 8:50 pm. The patient received the vaccine on 04-Aug-2021 at 9:45 am, almost 12 hours after the vial expired.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 10-Aug-2021: Follow-up information included race, ethnicity and vaccine facility information updated
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discolouration, Vaccination site erythema, Vaccination site mass, Vaccination site pain, Vaccination site pruritus
Clinical narrative: like purplish red color; size of a baseball; really red; Itching on the surface of her skin at the injection site; Burning on the surface of her skin at the injection site/sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (like purplish red color), VACCINATION SITE MASS (size of a baseball), VACCINATION SITE PRURITUS (Itching on the surface of her skin at the injection site), VACCINATION SITE PAIN (Burning on the surface of her skin at the injection site/sore) and VACCINATION SITE ERYTHEMA (really red) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0502C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jul-2021, the patient experienced VACCINATION SITE PRURITUS (Itching on the surface of her skin at the injection site) and VACCINATION SITE PAIN (Burning on the surface of her skin at the injection site/sore). On an unknown date, the patient experienced VACCINATION SITE DISCOLOURATION (like purplish red color), VACCINATION SITE MASS (size of a baseball) and VACCINATION SITE ERYTHEMA (really red). At the time of the report, VACCINATION SITE DISCOLOURATION (like purplish red color), VACCINATION SITE MASS (size of a baseball), VACCINATION SITE PRURITUS (Itching on the surface of her skin at the injection site), VACCINATION SITE PAIN (Burning on the surface of her skin at the injection site/sore) and VACCINATION SITE ERYTHEMA (really red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site discolouration, Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: sore arm; he noticed a big red circle around the injection site, which is white in the middle; he noticed a big red circle around the injection site, which is white in the middle and warm as well; he noticed a big red circle around the injection site; injection site started itching badly; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), VACCINATION SITE DISCOLOURATION (he noticed a big red circle around the injection site, which is white in the middle), VACCINATION SITE WARMTH (he noticed a big red circle around the injection site, which is white in the middle and warm as well), VACCINATION SITE ERYTHEMA (he noticed a big red circle around the injection site) and VACCINATION SITE PRURITUS (injection site started itching badly) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 059E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Aug-2021, the patient experienced VACCINATION SITE PRURITUS (injection site started itching badly). On 04-Aug-2021, the patient experienced VACCINATION SITE DISCOLOURATION (he noticed a big red circle around the injection site, which is white in the middle), VACCINATION SITE WARMTH (he noticed a big red circle around the injection site, which is white in the middle and warm as well) and VACCINATION SITE ERYTHEMA (he noticed a big red circle around the injection site). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) had resolved and VACCINATION SITE DISCOLOURATION (he noticed a big red circle around the injection site, which is white in the middle), VACCINATION SITE WARMTH (he noticed a big red circle around the injection site, which is white in the middle and warm as well), VACCINATION SITE ERYTHEMA (he noticed a big red circle around the injection site) and VACCINATION SITE PRURITUS (injection site started itching badly) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included vitamins and topical medications for acne was reported. Patient advised did not take anything to treat the symptoms.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Hypoaesthesia, Onychalgia, Paraesthesia oral, Product dose omission issue
Clinical narrative: Has not received the second dose (>35 days); Numbness and tingling were so bad in fingernails hurt; Light headedness and dizziness; Numbness and tingling in hands; Light headed and dizzy; Tingling in lower jaw; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Light headed and dizzy), PARAESTHESIA ORAL (Tingling in lower jaw), HYPOAESTHESIA (Numbness and tingling in hands), ONYCHALGIA (Numbness and tingling were so bad in fingernails hurt) and DIZZINESS (Light headedness and dizziness) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced DIZZINESS (Light headed and dizzy) and PARAESTHESIA ORAL (Tingling in lower jaw). In March 2021, the patient experienced HYPOAESTHESIA (Numbness and tingling in hands). In April 2021, the patient experienced ONYCHALGIA (Numbness and tingling were so bad in fingernails hurt) and DIZZINESS (Light headedness and dizziness). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Has not received the second dose (>35 days)). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 24-Feb-2021, DIZZINESS (Light headed and dizzy) and PARAESTHESIA ORAL (Tingling in lower jaw) had resolved. At the time of the report, HYPOAESTHESIA (Numbness and tingling in hands), ONYCHALGIA (Numbness and tingling were so bad in fingernails hurt), DIZZINESS (Light headedness and dizziness) and PRODUCT DOSE OMISSION ISSUE (Has not received the second dose (>35 days)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided.  The patient were treated with  water, IV steroids and Benadryl.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Dizziness, Gait disturbance, Headache
Clinical narrative: I felt dizzy; I started shaking on my right side/ right leg is shaky; I got weak; my right leg is shaky, I'm not stable walking; I don't have the best appetite; nausea; I had headaches; I threw up; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (I felt dizzy), TREMOR (I started shaking on my right side/ right leg is shaky), ASTHENIA (I got weak), GAIT DISTURBANCE (my right leg is shaky, I'm not stable walking) and DECREASED APPETITE (I don't have the best appetite) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jul-2021, the patient experienced DIZZINESS (I felt dizzy), TREMOR (I started shaking on my right side/ right leg is shaky), ASTHENIA (I got weak), GAIT DISTURBANCE (my right leg is shaky, I'm not stable walking), DECREASED APPETITE (I don't have the best appetite), NAUSEA (nausea), HEADACHE (I had headaches) and VOMITING (I threw up). At the time of the report, DIZZINESS (I felt dizzy), TREMOR (I started shaking on my right side/ right leg is shaky), ASTHENIA (I got weak), GAIT DISTURBANCE (my right leg is shaky, I'm not stable walking), DECREASED APPETITE (I don't have the best appetite), NAUSEA (nausea), HEADACHE (I had headaches) and VOMITING (I threw up) had not resolved.            No relevant concomitant medications were reported.  No treatment information was provided.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Tremor, Vomiting
Clinical narrative: I felt dizzy; I started shaking on my right side/ right leg is shaky; I got weak; my right leg is shaky, I'm not stable walking; I don't have the best appetite; nausea; I had headaches; I threw up; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (I felt dizzy), TREMOR (I started shaking on my right side/ right leg is shaky), ASTHENIA (I got weak), GAIT DISTURBANCE (my right leg is shaky, I'm not stable walking) and DECREASED APPETITE (I don't have the best appetite) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jul-2021, the patient experienced DIZZINESS (I felt dizzy), TREMOR (I started shaking on my right side/ right leg is shaky), ASTHENIA (I got weak), GAIT DISTURBANCE (my right leg is shaky, I'm not stable walking), DECREASED APPETITE (I don't have the best appetite), NAUSEA (nausea), HEADACHE (I had headaches) and VOMITING (I threw up). At the time of the report, DIZZINESS (I felt dizzy), TREMOR (I started shaking on my right side/ right leg is shaky), ASTHENIA (I got weak), GAIT DISTURBANCE (my right leg is shaky, I'm not stable walking), DECREASED APPETITE (I don't have the best appetite), NAUSEA (nausea), HEADACHE (I had headaches) and VOMITING (I threw up) had not resolved.            No relevant concomitant medications were reported.  No treatment information was provided.
Age: 15.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 15 year old that received Moderna; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old that received Moderna) in a 15-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old that received Moderna). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old that received Moderna) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Did not get the second dose and it's been more than 36 days from the first; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Did not get the second dose and it's been more than 36 days from the first) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jul-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Did not get the second dose and it's been more than 36 days from the first). On 15-Jul-2021, PRODUCT DOSE OMISSION ISSUE (Did not get the second dose and it's been more than 36 days from the first) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Blood glucose increased, Glycosylated haemoglobin increased
Clinical narrative: Rise in blood sugar levels; rise in hemoglobin A1c; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (Rise in blood sugar levels) and GLYCOSYLATED HAEMOGLOBIN INCREASED (rise in hemoglobin A1c) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLOOD GLUCOSE INCREASED (Rise in blood sugar levels) and GLYCOSYLATED HAEMOGLOBIN INCREASED (rise in hemoglobin A1c). At the time of the report, BLOOD GLUCOSE INCREASED (Rise in blood sugar levels) and GLYCOSYLATED HAEMOGLOBIN INCREASED (rise in hemoglobin A1c) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication information is provided by the reporter. No treatment information provided. Spouse had a readjustment in insulin pump settings was described by the caller. According to reporter's endocrinologist same symptoms than reporter's spouse were experienced by 30 other diabetic patients after receiving Moderna vaccine.
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Blood glucose increased, Glycosylated haemoglobin, Glycosylated haemoglobin increased
Clinical narrative: Rise in blood sugar levels; Rise in hemoglobin A1c; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (Rise in blood sugar levels) and GLYCOSYLATED HAEMOGLOBIN INCREASED (Rise in hemoglobin A1c) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLOOD GLUCOSE INCREASED (Rise in blood sugar levels) and GLYCOSYLATED HAEMOGLOBIN INCREASED (Rise in hemoglobin A1c). At the time of the report, BLOOD GLUCOSE INCREASED (Rise in blood sugar levels) and GLYCOSYLATED HAEMOGLOBIN INCREASED (Rise in hemoglobin A1c) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: increased (High) Rise in blood sugar levels. On an unknown date, Glycosylated haemoglobin: increased (High) Rise in hemoglobin A1c.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient also had to change the insulin pump settings after receiving Moderna vaccine. No concomitant medication were provided. No treatment details were provided.   This case was linked to MOD-2021-074042 (Patient Link).